Stocks with increasing unusual option volume: ABT IBM XOM HBI ROKU
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Abbott Labs (ABT) PT Raised to $65 at Jefferies
October 19, 2017 9:25 AM EDTJefferies raised its price target on Abbott Labs (NYSE: ABT) to $65.00 (from $58.00) while maintaining a Buy rating following the company's 3Q earnings report. Org growth in 3Q of +5.6% was the best in 2 years and largely validates the recent portfolio moves. Driving the performance... More
Abbott Labs (ABT) PT Raised to $63 at Stifel Following 3Q Release
October 18, 2017 5:06 PM EDTStifel raised its price target on Abbott Labs (NYSE: ABT) to $63.00 (from $58.00) while maintaining a Buy rating following the company's 3Q earnings report. The company reported above-expectation 5.6% comparable operational sales growth and above-consensus EPS at $0.66 (vs. $0.65 Consensus). positive 3Q highlights included: key product approvals, improving pipeline... More
